EUVIMEDEUVIMED entdecken
Crossref

Optimization of Genome-Wide CRISPR Screens Using Dual-Guide RNA Infection with Cas9 Electroporation (DICE)

Caitlin Purman, Charles Lu, Apexa Modi, Vinny Vijaykumar, Michael J Flister, Anneke I den Hollander, Sabah Kadri, Joshua D Stender iD

The CRISPR Journal · 01.06.2026 · 9 (3) · 141-150

DOI: 10.1177/25731599261448141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 14.05.2026. Verfasst von Caitlin Purman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Research Center, AbbVie, Inc., North Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Electroporation, CRISPR-Cas Systems, RNA, Guide, CRISPR-Cas Systems, Gene Editing. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single-guide RNA (sgRNA) lentiviral infection with Cas9 protein electroporation (SLICE) enables CRISPR screening in primary cell types that require transient Cas9 expression, yet is limited by scalability and robustness. Here, we introduce dual guide RNA infection with Cas9 electroporation (DICE), which expresses two guides from the same lentiviral construct that target the same gene. In genome-wide screens, DICE outperformed SLICE in defining essential genes and modulators of PD-L1 expression in Interferon-gamma-activated THP1 cells. Collectively, these data demonstrate that DICE can be utilized for reduced-scale CRISPR screens in cell types with transient Cas9 protein expression without sacrificing screening quality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectroporationCRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsGene EditingCRISPR-Associated Protein 9HumansClustered Regularly Interspaced Short Palindromic RepeatsLentivirusHEK293 CellsTHP-1 Cells

Substanzen

RNA, Guide, CRISPR-Cas SystemsCRISPR-Associated Protein 9

Autor:innen und Institutionen

  • Genomics Research Center, AbbVie, Inc., North Chicago, Illinois, USA.
  • Oncology Discovery, AbbVie, Inc., North Chicago, Illinois, USA.
  • Oncology Research Unit, Pfizer Inc, Bothell, Washington, USA.

ORCID-Profile: Joshua D Stender

Zitieren

APA

Purman, C., Lu, C., Modi, A., Vijaykumar, V., Flister, M. J., den Hollander, A. I., Kadri, S., & Stender, J. D. (2026). Optimization of Genome-Wide CRISPR Screens Using Dual-Guide RNA Infection with Cas9 Electroporation (DICE). The CRISPR Journal, 9(3), 141-150. https://doi.org/10.1177/25731599261448141

Vancouver

Purman C, Lu C, Modi A, Vijaykumar V, Flister MJ, den Hollander AI, et al. Optimization of Genome-Wide CRISPR Screens Using Dual-Guide RNA Infection with Cas9 Electroporation (DICE). The CRISPR Journal. 2026;9(3):141-150. doi:10.1177/25731599261448141

BibTeX
@article{Purman2026,
  author = {Purman, Caitlin and Lu, Charles and Modi, Apexa and Vijaykumar, Vinny and Flister, Michael J and den Hollander, Anneke I and Kadri, Sabah and Stender, Joshua D},
  title = {Optimization of Genome-Wide CRISPR Screens Using Dual-Guide RNA Infection with Cas9 Electroporation (DICE)},
  journal = {The CRISPR Journal},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {141--150},
  doi = {10.1177/25731599261448141}
}
Kostenlos starten →